A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
This project is designed to evaluating the use of combination therapy of glucocorticoid and
metformin to decrease glucocorticoid side effects in participants with autoimmune
uveitis.This study also aims to evaluate the anti-inflammatory and immunosuppressive effects
of combination therapy.
Phase:
N/A
Details
Lead Sponsor:
Tianjin Medical University
Collaborators:
Peking Union Medical College Hospital Peking Union Medical College Hospital, Peking University First Hospital and Zhongshan Ophthalmic Center， Sun Yat-sen University Peking University First Hospital Zhongshan Ophthalmic Center, Sun Yat-sen University